Questions: B Cell Activation and Germinal Center Responses

Question 1

A patient has a genetic defect that prevents functional CD40L expression on T cells. Which antibody response would you most expect in this patient?

• A. Normal IgG and IgA responses, but no IgM production
• B. High-affinity, class-switched antibodies but no IgM
• C. Only low-affinity IgM antibodies, with severely impaired class switching and affinity maturation
• D. No antibody production at all — B cells require T cell help to survive

Answer: (C)

CD40-CD40L interaction (Signal 2) is required for germinal center formation. Without it, B cells can receive Signal 1 (BCR binding antigen) and may differentiate into short-lived plasmablasts producing low-affinity IgM, but cannot enter germinal centers to undergo somatic hypermutation (affinity maturation) or class switch recombination (IgG, IgA, IgE). This is exactly the immunodeficiency seen in Hyper-IgM syndrome, where patients have elevated IgM but virtually no other isotypes.

Question 2

Why does the two-signal requirement for B cell activation (BCR signal + CD40-CD40L) reduce inappropriate antibody production against self-antigens?

• A. It ensures only antigens recognized by BCRs can trigger B cells, filtering out non-protein antigens
• B. It requires T cell validation — T cells are less likely to be activated by self-antigens due to thymic selection
• C. It prevents B cells from dividing faster than the immune system can monitor
• D. It limits the number of B cell clones that can be activated simultaneously

Answer: (B)

The two-signal requirement acts as a safety checkpoint: a B cell that binds a self-antigen via its BCR (Signal 1) will not become fully activated unless a CD4+ Tfh cell — which recognizes antigen on MHC class II — also provides Signal 2. T cells undergo rigorous thymic selection that eliminates most self-reactive clones, so it is much less likely that a T cell will provide help for a B cell responding to self-antigen. This cross-checking between the B and T cell arms prevents autoimmune antibody production.

Question 3

Germinal centers are the site where B cells undergo somatic hypermutation and class switch recombination, generating high-affinity, class-switched antibodies.

• T. True
• F. False

Answer: True

Germinal centers are specialized microenvironments in secondary lymphoid organs (lymph nodes, spleen) where B cells rapidly proliferate and undergo two critical modifications: somatic hypermutation (random point mutations in antibody variable regions, allowing selection for higher affinity) and class switch recombination (changing the antibody constant region from IgM to IgG, IgA, or IgE). Both processes require sustained Tfh cell help. The germinal center reaction is what converts the early low-affinity IgM response into the durable high-affinity antibody responses that vaccines are designed to elicit.

Question 4

B cells can mount a complete, high-affinity antibody response upon binding their cognate antigen alone, without T cell help.

• T. True
• F. False

Answer: False

This is the primary misconception in this topic. Antigen binding (Signal 1) activates BCR signaling but is insufficient for full B cell activation in most cases. Signal 2 — CD40-CD40L contact and cytokines (IL-21, IL-4) from activated Tfh cells — is required for germinal center entry, somatic hypermutation, and class switching. Without T cell help, B cells produce only short-lived, low-affinity IgM. T-independent antigens (certain polysaccharides) can trigger some antibody production without T cell help, but these responses are weak and do not generate memory.

Question 5

Why do germinal centers take 3–4 days to form after initial antigen exposure, and what does this delay tell us about the biological requirements for high-quality antibody responses?

Model answer: The delay reflects the time required for B cells and T cells to independently become activated, migrate to the correct anatomical locations (the B-T border in secondary lymphoid organs), interact to establish CD40-CD40L contact, and then begin the clonal expansion and architectural organization that constitutes a germinal center. High-quality antibody responses cannot be rushed — germinal centers require an ongoing collaboration between B cells, Tfh cells, and follicular dendritic cells. The delay explains why the early immune response (days 1–3) is dominated by low-affinity IgM from quickly-differentiated plasmablasts, while the later, more effective response emerges from the germinal center over weeks.

Understanding this timeline is important for vaccine design: vaccines that fail to sustain Tfh-B cell interaction long enough will not generate robust germinal centers, and thus will produce only short-lived, low-affinity protection.